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Tobacco, hypertension, and vascular disease: Risk factors for for each individual. Lindeman, Tobin, and Shock studied
renal functional decline in an older population. longitudinal renal function in 446 individuals aged 22
Background. A decline in renal function with age has been to 96 years who had at least five creatinine clearancenoted in some but not all individuals. The purpose of this study
determinations performed at 12- to 18-month intervalswas to identify risk factors associated with a clinically significant
in the Baltimore Longitudinal Study of Aging [3]. In thisincrease in serum creatinine (of at least 0.3 mg/dL) in an older
nondiabetic population. study, there was no change in renal function for up to
Methods. A retrospective case-control study was performed 30% of the individuals, while 73 of 446 (16%) partici-
analyzing data obtained from 4142 nondiabetic participants of pants sustained a statistically significant decline in func-the Cardiovascular Health Study Cohort, all at least 65 years
tion. The decline in renal function with aging has seriousof age, who had two measurements of serum creatinine per-
repercussions. Decreased renal function with age mayformed at least three years apart. Cases were identified as
participants who developed an increase in serum creatinine of make older patients more vulnerable to such renal disor-
at least 0.3 mg/dL, with controls including participants who did ders as glomerulonephritis [4] and aminoglycoside neph-
not sustain such an increase.
rotoxicity [5] and may predispose them to the develop-Results. There was an increase in the serum creatinine of at
ment of ESRD.least 0.3 mg/dL in 2.8% of the population. In a multivariate
“best-fit” model adjusted for gender, weight, black race, base- While studies such as the Baltimore Longitudinal
line serum creatinine, and age, the following factors were asso- Study of Aging have focused on changes that occur in
ciated with an increase in serum creatinine: number of ciga- the aging of a relatively healthy population, the purpose
rettes smoked per day, systolic blood pressure, and maximum
of the current investigation was to look at clinically sig-internal carotid artery intimal thickness.
nificant declines in renal function in a population-basedConclusions. These data suggest that three very preventable
or treatable conditions—hypertension, smoking, and prevalent sample of older adults. We hypothesized that three fac-
vascular disease, which are associated with large and small tors (hypertension, atherosclerosis, and smoking) known
vessel disease—are highly associated with clinically important to affect the renal vasculature and microvasculaturechanges in renal function in an older population.
would be associated with a large proportion of the clini-
cally significant renal functional deterioration.
Hypertension has long been associated with changes
Patients greater than 60 years of age form the most
in renal structure and function [6]. It has been associated
rapidly growing segment of the end-stage renal disease
with both renal artery stenosis [7] and microvascular
(ESRD) population [1]. The cause of ESRD in over
changes in the renal circulation [8]. In the same way,
25% of patients is unknown [2]. Understanding factors
both tobacco usage and extrarenal prevalent vascularassociated with renal functional decline in older adults
disease have been associated with renal artery stenosisis therefore an important public health issue. With aging,
[9, 10] and changes in the renal microvasculature [11, 12].the decline in renal function is not uniform, but varies
Smoking has recently become of greater interest in terms
of its potential effect on renal function [13].
The purpose of this study was to evaluate clinicallyKey words: smoking, prevention of renal disease, blood pressure, ciga-
rettes, carotid artery intimal thickness, ESRD. significant changes in serum creatinine in a population
that had two assessments of serum creatinine performedReceived for publication December 16, 1998
at least three years apart. An increase in serum creatinineand in revised form October 12, 1999
Accepted for publication December 1, 1999 of at least 0.3 mg/dL was considered clinically important,
as such changes virtually always represent true declinesÓ 2000 by the International Society of Nephrology
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in renal function, whereas changes of 0.1 and 0.2 mg/dL and Sons Limited, Sussex, UK). The average of the two
measurements of the first and fifth Korotkoff sounds wasare quite common and frequently represent differences
that are due to individual variability in daily serum creati- used to determine systolic and diastolic blood pressures.
Venipuncture was performed early in the clinic visit.nine values [14, 15].
Multiple aliquots of plasma or serum were prepared and
frozen at 2708C and were shipped weekly on dry ice to
METHODS
the Central Blood Analysis Laboratory, where analyses
The Cardiovascular Health Study is a population- were performed on the Kodak Ektachem 700 Analyzer
based cohort study of coronary artery disease and stroke (Eastman Kodak Corp., Rochester, NY, USA). Duplex
in individuals greater than 65 years of age. The original ultrasonography of the carotid arteries was performed
study design called for enrollment of 1250 participants with a Toshiba SSA-270 A (Toshiba American Medical
in each of four communities: Forsyth County, NC; Sacra- Systems, Tustin, CA, USA). B-mode imaging was per-
mento County, CA; Washington County, MD; and Alle- formed to detect thickening of the arterial wall, disrup-
gheny County, PA, USA. Each community sample was tion of normal wall interfaces, and development of focal
obtained through random sampling of Medicare eligibil- plaques bilaterally. M-mode, two-dimensional, and Dopp-
ity lists of the Health Care Financing Administration. ler echocardiographic examinations were performed
Those eligible to participate included all persons living with the Toshiba SSH-160A (Toshiba Medical Systems,
in each individual household sampled who were at least Tustin, CA, USA), equipped with 2.5 and 3.75 MHz
65 years of age, were noninstitutionalized, were expected transducers. For the original cohort, at the three year
to be in the area for the three-year follow-up, were able follow-up, the participant history, physical examination,
to give informed consent, and did not require a proxy and laboratory determinations were repeated. For the
respondent at baseline. Individuals who were wheelchair- added black cohort, these studies were conducted at four
bound or receiving hospice treatment, radiation therapy, years of follow-up instead of three years of follow-up.
or chemotherapy for cancer were not included. Seventy The following variables pertinent to these analyses were
percent of the cohort (3654 individuals) were selected obtained: age, race, gender, weight, serum albumin, cho-
from 11,955 letters mailed to individuals identified from lesterol, and creatinine. Information regarding medication
eligibility lists, and 30% were recruited from eligible usage was obtained at each annual examination, with anal-
members in the sampled households. The enrolled parti- yses based on medication usage at baseline. Medications
cipants in the original CHS cohort were younger, more evaluated included angiotensin-converting enzyme in-
highly educated, and more likely to be married than the hibitors, diuretics, calcium channel blockers, cholesterol-
baseline population [16, 17]. In 1992, 687 additional black lowering medications, and nonsteroidal anti-inflamma-
participants were recruited from Forsyth County, NC, tory medications. Prevalent cardiovascular disease was
Sacramento, CA, and Pittsburgh, PA, by similar methods defined as present if participants had a confirmed history
as the original cohort recruitment. of myocardial infarction, stroke, or peripheral vascular
The baseline examination consisted of a home inter- disease at baseline. Subclinical atherosclerosis was as-
view and a clinic examination. During the home visit, sessed using the average intima-media wall thickness in
study interviewers asked to see all prescription medica- the common carotid artery or the average maximum
tions that the participants had taken in the previous two intima-media wall thickness in the internal carotid artery
weeks and asked for the frequency of usage. Activities from the baseline ultrasound examination. Pack years
of daily living and independent activities of daily living of tobacco usage were calculated at baseline. Current
were assessed by self-report. Participants were considered smoking (cigarettes per day) was determined from the
to have a definite history of hypertension if they reported data derived at follow-up visits by asking the participant
a history of hypertension and use of antihypertensive the average number of cigarettes smoked per day for
medications. Participants reporting a history of myocar- the prior 30 days.
dial infarction, stroke, or peripheral vascular disease con-
Statistical analysisfirmed by their medical record were considered to have
these conditions. Participants were considered to be dia- Analyses were performed for all individuals who had
betic if they reported a history of diabetes mellitus and measurements of serum creatinine performed at both
were taking insulin or oral hypoglycemic medications. the baseline and follow-up examinations. Given the asso-
Participants were asked to fast 12 hours before coming ciation of diabetes mellitus with diabetic nephropathy,
to their clinic appointment; all examinations were sched- participants with diabetes mellitus were excluded from
uled in the morning. Blood pressure was measured in the analysis. Differences between baseline and follow-
the right arm of seated participants after a five-minute up serum creatinine levels were determined. A logistic
rest using an appropriately sized cuff and a Hawksley regression analysis was performed comparing individuals
who sustained an increase in serum creatinine of at leastrandom zero sphygmomanometer, model 7076 (Hawksley
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Table 1. Characteristics of the non-diabetic cohort by gender0.3 mg/dL with those who did not. Logistic regression
analysis techniques were performed using SAS statistical Characteristic Men Women
software (Cary, NC, USA). The association between the Race (% White) 95.6 95.0
Race (% Black) 3.8 4.5previously described clinical parameters and an increase
Age (y) 73.465.8 72.465.4in creatinine were investigated in multivariate models.
Weight (lbs.) 173626 146630
The variables significantly associated with large changes Use of antihypertensive (%) 41.3 43.5
Smoking statusin serum creatinine were determined using a stepwise
Never 32.0 56.7logistic procedure. Given the known associations between Past 57.7 30.5
creatinine production, gender, race, age, and weight [18], Current 10.3 12.8
Cigarettes smoked per day at year 5 1.0464.7 1.2964.7these variables were forced into all models. In addition,
Pack years of tobacco usage 26631 12621since the change in serum creatinine is dependent on the History of hypertension % 41.3 45.2
baseline serum creatinine, the baseline serum creatinine Atherosclerosis % 19.5 8.2
Baseline serum creatinine mg/dL 1.260.26 0.9260.22was also included in all models. Variables were then
Serum cholesterol mg/dL 199.4635.4 221.4637.8entered into the model and removed if they did not reach HDL cholesterol mg/dL 48.0612.6 60.0615.8
LDL cholesterol mg/dL 124.9633.0 134.5636.1a statistical significance level of P , 0.05.
Systolic blood pressure mm Hg 135621 136622To further explore the effect of cigarette smoking in
Diastolic blood pressure mm Hg 72611 69611
different groups, a stratified analysis was carried out,
Continuous variables represented by the mean 6 the standard deviation.
first stratifying for race and then stratifying for gender. Discrete variables are represented by percentage of cohort with condition.
Dose response analyses of current cigarette use were
performed by comparing participants categorized by the
average number of cigarettes smoked per day. The test
of change in serum creatinine. Table 1 shows the charac-of linear trend across these groups was performed by
teristics of the cohort by gender. There were 497 (12%)comparing the log likelihoods of a logistic model with a
black participants in the nondiabetic cohort. Figure 1linear term reflecting group (coded 0 through 3) against
shows the baseline serum creatinine values for men and
a logistic model with three indicator variables reflecting
women. The mean serum creatinine level was 1.2 mg/dL
cigarette use group. in men and 0.92 mg/dL in women. Figure 2 is a histogram
Given the low prevalence of an 0.3 mg/dL increase in showing changes in serum creatinine from baseline.
serum creatinine, it is assumed that the relative risk There was an increase in serum creatinine of at least 0.3
closely approximates the odds ratio in this study. mg/dL in 2.8% of these participants.
After review of the previously mentioned information, Table 2 shows the results of logistic regression analysis
several analyses were performed. First, a linear model for factors associated with changes in serum creatinine
was created with change in inverse serum creatinine as after adjustment for age, gender, and weight. Race, to-
a continuous outcome variable. Gender, weight, age, and bacco usage, prevalent cardiovascular disease, average
race were again forced into the model. Another logistic maximum intima-media wall thickness in the internal
regression model was created with an attempt to model carotid artery from the baseline ultrasound examination,
percentage change in renal function as the outcome vari- and systolic and diastolic blood pressure were all associ-
able. Percentage change in renal function was denoted ated with an increase in the serum creatinine of 0.3 mg/dL
as the percentage change in reciprocal serum creatinine or more. Of note, nonsteroidal anti-inflammatory medi-
between the two measurements of serum creatinine. For cation usage, activities of daily living, independent activi-
the logistic regression model, a change of 224% was ties of daily living, left ventricular ejection fraction, serum
used as a cutoff, with patients who sustained a change total cholesterol, high-density lipoprotein cholesterol,
in renal function of this magnitude representing 5% of and low-density lipoprotein cholesterol were not signifi-
the CHS population. cantly associated with changes in creatinine.
Table 3 shows a multivariate “best-fit” model into
which weight, gender, age, black race, and baseline se-
RESULTS rum creatinine have been forced. As can be seen, systolic
There were 5888 participants, of whom 502 diabetics blood pressure, average maximum intima-media wall
were excluded from these analyses. Of the nondiabetic thickness in the internal carotid artery from the baseline
participants at the time of follow-up, 352 (6.5%) individ- ultrasound examination, and tobacco usage were all strong
uals had died; 717 (13.3%) did not have a clinic visit, predictors of an increase in serum creatinine. There was
and 175 (3.2%) had clinic visits, but no laboratory mea- a significant growing risk of creatinine increase with in-
surements of serum creatinine were obtained at either or creases in the number of cigarettes smoked.
both visits. There remained 4142 (76.9% of the original To further explore the relationship between smoking
and the risk of renal functional decline, participants werenondiabetic cohort) who were included in these analyses
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Fig. 1. Baseline serum creatinine by gender.
Symbols are: (h) females; ( ) males.
Fig. 2. Changes in serum creatinine by gen-
der. Symbols are: (h) females; (j) males.
divided into groups according to current smoking status. Given differences in follow-up, the analysis was next
stratified by race. For the black participants, after adjust-Figure 3 shows the odds ratio of a creatinine increase
for participants grouped according to smoking habits. ment for age, weight, gender, and baseline serum creati-
nine, no other variable was significantly associated withWith an increase in tobacco usage, there was an increased
risk of serum creatinine rise, up to 20 cigarettes per a large change in serum creatinine. However, the power
was significantly decreased, as there were only 37 blacksday. The hypothesis of a linear trend for cigarette use,
indicating a dose response, was not rejected in the logistic experiencing a large serum creatinine change. The strati-
fied model for white participants was very similar to themodel. While increasing cigarette consumption was asso-
ciated with an increased odds ratio of serum creatinine overall model in Table 3. The analysis was then stratified
by gender. For female participants, only systolic bloodincrease, it is important to note that only 2.8% of the
population experienced an increase in serum creatinine, pressure was associated with a large creatinine change
[1.02 (1.10 to 1.37) increased the odds ratio for each 10and only 8.8% of men and 9.8% of women in the study
were current smokers, resulting in an increase in serum mm Hg increase in systolic blood pressure]. For male
participants, the model was again similar to the modelcreatinine of 0.3 mg/dL in only 14 smokers.
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Table 2. Logistic regression models on large change in serum creatinine ($0.3 mg/dL) for each individual characteristic after adjusting for
age, weight, and gender
Odds ratio
Parameter Reference group Risk group (95% confidence interval) P value
Gendera Female Male 1.4 (0.92–2.1) 0.12
Weightb " by 10 lb. 1.06 (0.99–1.13) 0.11
Agec " by 5 y 1.52 (1.30–1.77) 0.0001
Black race Nonblack Black 0.64 (0.20–2.1) 0.45
Antihypertensive usage Non-user User 1.7 (1.1–2.4) 0.008
NSAID usage Non-user User 1.1 (0.64–1.96) 0.69
Ever smoker at baseline No Yes 1.2 (0.81–1.8) 0.36
Current smoker (at baseline) No Yes 2.1 (1.3–3.6) 0.0053
Number of cigarettes smoked per day at year 5 " of 5 per day 1.25 (1.09–1.44) 0.0017
History of hypertension No Yes 2.10 (1.4–3.1) 0.0001
Atherosclerosis Absent Present 2.43 (1.6–3.8) 0.0001
Systolic blood pressure " of 10 mm Hg 1.16 (1.07–1.26) 0.0003
Diastolic blood pressure " of 10 mm Hg 1.13 (0.96–1.34) 0.14
Mean arterial pressure " of 10 mm Hg 1.23 (1.06–1.41) 0.005
Serum creatinine " of 1 mg/dL 2.9 (1.3–4.2) 0.007
Serum albumin " by 1 g/dL 0.52 (0.27–0.99) 0.05
Serum cholesterol " of 1 mg/dL 1.00 (1.0–1.0) 0.74
LDL cholesterol " of 1 mg/dL 1.00 (1.0–1.0) 0.84
HDL cholesterol " of 1 mg/dL 0.99 (0.99–1.0) 0.047
Common carotid thickness " by 10 mm 1.10 (1.01–1.19) 0.025
Internal carotid thickness " by 10 mm 1.05 (1.01–1.08) 0.005
aAdjusted for weight and age
bAdjusted for gender and age
cAdjusted for gender and weight
Table 3. “Best fit” logistic regression model for changes in serum creatinine $0.3 mg/dL with gender, age, weight, and baseline serum
creatinine included in the model
Odds ratio
Parameter Reference group Risk group (95% confidence interval) P value
Gender Male Female 0.87 (0.56–1.35) 0.53
Weight " by 10 lb. 1.12 (1.05–1.20) 0.0005
Age " by 5 y 1.66 (1.40–1.97) 0.0001
Baseline serum creatinine " by 1 mg/dL 1.12 (1.06–1.19) 0.0001
Carotid intimal thickness " by 0.1 mm 1.52 (1.01–1.08) 0.011
Systolic blood pressure " of 10 mm Hg 1.16 (1.07–1.26) 0.0003
Number of cigarettes smoked " by 5 cigarettes/day 1.31 (1.12–1.52) 0.0011
in Table 3, with black race, baseline serum creatinine, DISCUSSION
atherosclerosis, and tobacco usage associated with an In the present study, an increase in serum creatinine
increase in serum creatinine. was associated with several important characteristics.
In the multivariate best-fit model, which was created Systolic blood pressure was found to be a better predictor
using change in inverse serum creatinine as a continuous of renal decline than diastolic blood pressure or mean
outcome variable, male gender (P , 0.0002), black race arterial pressure, as has been noted by others [19, 20].
(P , 0.0001), declining serum albumin (P , 0.0001), Changes in renal function resulting from hypertension
and increasing systolic blood pressure (P , 0.0001) were could be related to either large or small vessel disease.
the only variables associated with increasing serum creat- Hypertension has been associated with renal artery ste-
inine. nosis [7], and hypertension has also been found in patho-
In the model looking at the percentage of change in logic investigations to be associated with renal arteriolar
renal function, the following variables were predictive intimal proliferation and medial hypertrophy [21]. The
of a greater than 24% decline in inverse serum creatinine: use of antihypertensive agents did not have a significant
male versus female gender, 3.40 (2.30–4.97); black versus impact on changes in serum creatinine, which is an issue
white race, 2.49 (1.78 to 3.49); nonsteroidal usage, 1.50 more fully addressed in another publication [22].
(1.04 to 2.16); increase in systolic blood pressure by 10 Smoking was highly associated with an increase in
mm Hg, 1.01 (1.00 to 1.02); and decrease in serum albu- serum creatinine. This increase was of special interest.
While an association between renal deterioration in dia-min by 10 g/L, 2.78 (1.70 to 4.76).
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more commonly in patients with moderate-to-severe ath-
erosclerosis than in those with mild atherosclerosis [25].
Independent associations between age, intrarenal vascu-
lar disease, and glomerulosclerosis were identified. Tracy
et al found that renal arteriolar hyalinization correlated
with raised lesions in the coronary arteries and aorta in
an autopsy study of individuals aged 25 to 54 years [11].
As can be seen in Figure 1, there was some variation
in baseline serum creatinine, including some participants
likely having renal insufficiency. Figure 2 demonstrates
that a decline in serum creatinine of 0.1 mg/dL was the
most frequent change in serum creatinine. This decline
likely represents a decrease in muscle mass and creati-
nine generation rather than “true” improvement in renal
function. An increase in serum creatinine of at least 0.3
Fig. 3. Adjusted odds ratios of a serum creatinine increase of at least
mg/dL occurred in approximately 3% of the population.0.3 mg/dL by tobacco usage.
This increase likely underestimates the number of parti-
cipants who had important renal functional decline. Sig-
nificant renal functional deterioration, when associated
betic nephropathy and smoking has been described [23], with muscle wasting from disease and aging, may result
there is very little information regarding the renal effects in a stable serum creatinine or only a mild increase. The
of tobacco usage in the general population. Smoking has occurrence of renal functional decline in at least 3%
been noted to increase the risk of ESRD in individuals of the aging United States population places numerous
screened in the Multiple Risk Factors Intervention Trial individuals at risk for the development of future ESRD
[24]. In addition, smoking is an important predictor of and mortality [26], and has broad public health implica-
renovascular disease [10], as well as pathologic changes tions.
in the renal microcirculation. In an autopsy study smok- There are many limitations to the use of serum creati-
ing was associated with increased intimal thickening in nine as a marker for renal function. Serum creatinine is
renal arterioles ,555 mm in diameter [12]. In the current determined not only by glomerular filtration rate, but
study, an increase in current cigarette consumption was also tubular secretion and creatinine production [27].
associated with worsening renal function. The finding With aging comes a decrease in muscle mass and a de-
of an association between current cigarette use and an crease in creatinine production [18], which results in
increase in serum creatinine suggests that even in older variability in the relationship between serum creatinine
individuals, smoking cessation is of significant impor- and glomerular filtration rate. In addition, while small
tance in preserving health. changes may reflect large differences in glomerular fil-
When the analysis was stratified for race and then for tration rate, small changes may also represent this daily
gender, it was found that the association of tobacco usage variation in serum creatinine. Changes in serum creati-
with serum creatinine increase was seen in men but not nine of 0.1 mg/dL were common in our study and fre-
women, and white race but not black race. This may be quently may have been the result of such variation. In
due to the fact that in our cohort cigarette smoking a longitudinal study of urinary creatinine and creatinine
occurred at higher levels in men compared with women, clearances in normal subjects, there was a 14% within
and there were fewer events in African American patients, individual variability in serum creatinine [28], reflecting
which may not have allowed enough statistical power. an absolute change in serum creatinine of approximately
Finally, average maximum intima-media wall thickness 0.1 to 0.2 mg/dL. Sterner, Wroblewski, and Rosen noted
in the internal carotid artery from the baseline ultrasound a 30% increase in serum creatinine levels associated with
examination was highly associated with serum creatinine an increased protein intake [15]. For this reason, in our
change. These changes could be related to either large study, changes in serum creatinine of 0.3 mg/dL or
or small vessel disease. Common and internal carotid greater were considered to be of clinical importance.
intima-media thickness correlated with serum creatinine Given that decreases in serum creatinine were unlikely
change in models, which adjusted for age, gender, weight, to represent improved renal function, but rather weight
and black race. Renal artery stenosis is extremely com- loss or decreased protein intake, and given that most
mon in older individuals; its presence is associated with changes in serum creatinine were very small and could
atherosclerosis occurring in other blood vessels [10]. In reflect daily variation in laboratory test results or creati-
an autopsy study of patients without clinically overt renal nine production, a linear model with the change in serum
creatinine analyzed as a continuous dependent variabledisease, Kasiske et al found glomerulosclerosis to occur
Bleyer et al: Correlates of serum creatinine increases2078
was considered to have significant shortcomings com- The finding of smoking, prevalent cardiovascular dis-
ease, and systolic hypertension as risk factors for in-pared with a model specifically identifying participants
creases in serum creatinine is noteworthy for severalwith clinically significant increases in serum creatinine.
reasons. First, these findings point to atherosclerosis—A linear model would give equal weight to a decline in
likely both small and large vessel disease—being ofserum creatinine of 0.1 mg/dL (likely not to represent
marked importance in pathophysiologic changes in se-improved renal function) with an increase in serum creat-
rum creatinine over time. When the etiology of ESRDinine of 0.1 mg/dL. Moreover, because of the predomi-
is investigated, emphasis is usually placed on conditionsnant number of patients with a change in serum creati-
such as glomerulonephritis or inherited cystic disease.nine of less than 0.1 mg/dL, the development of the
This study highlights a growing belief that vascular dis-model would depend almost exclusively on very small
ease is important in the development of renal failurechanges in serum creatinine, which may be too small to
and potentially ESRD. Large-vessel renal disease is be-identify true changes in renal function.
coming much easier to diagnose because of techniquesWhen a linear model with changes in inverse serum
such as renal duplex sonography [32] and magnetic reso-creatinine was created, systolic blood pressure, black
nance imaging [33]. However, small-vessel renal diseaserace, and declining serum albumin were all significant.
is extremely difficult to diagnose in the clinical settingIn addition, male gender was highly associated with wors-
and may be the cause of ESRD in some of the 25%ening serum creatinine. This is likely because male pa-
of older patients who develop ESRD from presentlytients would have more muscle mass and would be more
unknown etiologies.likely to preserve muscle mass. Changes in serum creati-
An alternate potential explanation for the rise in se-nine in these patients would likely be more reflective of
rum creatinine is that participants with prevalent cardio-changes in renal function than changes in nutritional
vascular disease, tobacco abuse, and systolic hyperten-status. Female participants would be likely to have less
sion are in general more frail and are more likely to bemuscle mass and more likely to have a decline in serum
exposed to insults such as hypotension or sepsis, whichcreatinine with stable renal function compared with
could lead to acute tubular necrosis. In the univariatemales. Other variables that were significant with the lo-
model, individuals with a low serum albumin were alsogistic model were not significant in the linear model
more likely to develop increases in serum creatinine.because of the many small changes in serum creatinine
However, other markers of sickness, such as left ventricu-and the imprecision of this measurement.
lar ejection fraction or the ability to perform activitiesIn addition to analyzing the decline in renal function,
of daily living, were not associated with increases inthe percentage decline in renal function was also evalu-
creatinine in either models adjusting only for gender,ated. A greater than 24% decline in inverse serum creati-
age, and weight, or in the “best-fit” multivariate model.nine was experienced by 5% of the Cardiovascular
It is important and significant that current smokingHealth Study population. Factors associated with this
habits and elevated systolic blood pressure—two condi-included black race, systolic blood pressure, serum albu-
tions amenable to treatment—were significant predictorsmin, and nonsteroidal usage. In addition to change in
of renal functional decline in individuals at least 65 yearsserum creatinine, the percentage decline in renal func-
of age. These findings discourage the notion that yearstion is dependent on renal reserve, baseline renal func-
of hypertension and smoking have already resulted intion, and the relationship between loss of renal function
damage in this age group, and therefore, their continuedand baseline renal function.
presence in the older population is unlikely to affectA weakness of this study is that there was an interval
outcome. The results of this study indicate that cessationfollow-up of four years between serum creatinine mea-
of smoking and reduction in systolic blood pressure insurements for most of the black participants in the cohort
people over 65 could result in decreased risks of renaland only three years for the white participants. This
insufficiency in this older group.allowed a longer time for black participants to develop
progression of renal insufficiency. The increased risk of ACKNOWLEDGMENTS
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